Sign up United Kingdom
Vertex Pharmaceuticals (NASDAQ:VRTX)

Vertex Pharmaceuticals (NASDAQ:VRTX)


Share Price
$ 165.92
Change
-0.75 (-0.45 %)
Market Cap
$42,402.19 m
Proactive Investors - Run By Investors For Investors

Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

EPIC: VRTX
Market: NASDAQ:VRTX
52-week High/Low: $193.78 / $136.78
Sector: Health Care, Equipment & Services
Market Cap: $42,432.90M
Website: www.vrtx.com

Vertex Pharmaceuticals

www.vrtx.com

Interactive graph

col 3
col 4
col 5
col 6

Vertex Pharmaceuticals Timeline

Market Reports Including VRTX

VIEW ALL

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use